B-cell chronic lymphocytic leukemia: a bird of a different feather
about
Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemiaMethylation and silencing of protein tyrosine phosphatase receptor type O in chronic lymphocytic leukemiaCurrent concepts in diagnosis and treatment of chronic lymphocytic leukemiaThe ATR-p53 pathway is suppressed in noncycling normal and malignant lymphocytesFunctional and prognostic role of ZAP-70 in chronic lymphocytic leukaemiaThe Ukrainian-American study of leukemia and related disorders among Chornobyl cleanup workers from Ukraine: III. Radiation risksProteomic analysis of chronic lymphocytic leukemia subtypes with mutated or unmutated Ig V(H) genes.Analysis of VH gene sequences using two web-based immunogenetics resources gives different results, but the affinity maturation status of chronic lymphocytic leukaemia clones as assessed from either of the resulting data sets has no prognostic signiAutoimmune cytopenias in chronic lymphocytic leukemia.Autoimmune thrombocytopenia: a complication of fludarabine therapy in the treatment of Waldenstrom's macroglobulinemiaEthacrynic acid exhibits selective toxicity to chronic lymphocytic leukemia cells by inhibition of the Wnt/beta-catenin pathway.Changes in T-cell subpopulations and cytokine network during early period of ibrutinib therapy in chronic lymphocytic leukemia patients: the significant decrease in T regulatory cells number.Lymphocyte activation gene 3: a novel therapeutic target in chronic lymphocytic leukemia.SLP76 integrates into the B-cell receptor signaling cascade in chronic lymphocytic leukemia cells and is associated with an aggressive disease courseIn vivo measurements document the dynamic cellular kinetics of chronic lymphocytic leukemia B cellsWnt signaling pathway protein LEF1 in cancer, as a biomarker for prognosis and a target for treatment.Molecular detection of the G(-248)A BAX promoter nucleotide change in B cell chronic lymphocytic leukaemiaBCMSUN, a candidate gene for B-cell chronic lymphocytic leukemia and mantle-cell lymphoma, has an independently expressed homolog on 1p22-p31, BCMSUN-like.Chronic lymphocytic leukemia modeled in mouse by targeted miR-29 expression.Influence of bone marrow stromal microenvironment on forodesine-induced responses in CLL primary cells.Historical aspects of chronic lymphocytic leukaemia.Morphological and immunophenotypic features of chronic lymphocytic leukemia.Biology of chronic lymphocytic leukemia.VSV oncolysis in combination with the BCL-2 inhibitor obatoclax overcomes apoptosis resistance in chronic lymphocytic leukemia.Myeloablative allografting for chronic lymphocytic leukemia: evidence for a potent graft-versus-leukemia effect associated with graft-versus-host disease.Targeting cholesterol synthesis increases chemoimmuno-sensitivity in chronic lymphocytic leukemia cells.Immune complexes and apoptosis in B-cell chronic lymphocytic leukemia.Chemokine receptors and stromal cells in the homing and homeostasis of chronic lymphocytic leukemia B cells.Apoptosis in lymphocytic leukemias and lymphomas.B-chronic lymphocytic leukemia: practical aspects.Peptides that bind specifically to an antibody from a chronic lymphocytic leukemia clone expressing unmutated immunoglobulin variable region genes.Monocyte-derived dendritic cells in chronic lymphocytic leukemia.SET oncoprotein overexpression in B-cell chronic lymphocytic leukemia and non-Hodgkin lymphoma: a predictor of aggressive disease and a new treatment target.The novel member of the BCL2 gene family, BCL2L12, is substantially elevated in chronic lymphocytic leukemia patients, supporting its value as a significant biomarker.Immunoglobulin mutational status detected through single-round amplification of partial V(H) region represents a good prognostic marker for clinical outcome in chronic lymphocytic leukemia.Stem cell transplantation for chronic lymphocytic leukemia: should not more patients get a transplant?The rate of in vitro fludarabine-induced peripheral blood and bone marrow cell apoptosis may predict the chemotherapy outcome in patients with chronic lymphocytic leukemiaIL-8 secreted in a macrophage migration-inhibitory factor- and CD74-dependent manner regulates B cell chronic lymphocytic leukemia survival.Microenvironmental interactions and survival of CLL B-cells.Bodyguards and assassins: Bcl-2 family proteins and apoptosis control in chronic lymphocytic leukaemia.
P2860
Q24539231-9FDFBBD2-62D7-4EFA-B4C6-09607239BBB4Q24619893-4428B751-3517-44C5-8C3E-88C17348910AQ26770471-F9E5254C-E7AA-40EE-A033-9DC2306A042EQ28241779-88564227-47C9-4853-B9F2-D051EFADA9CAQ28282822-B4AE760E-CA89-4151-BB44-D1ECC71F3D3CQ28394934-EB71166B-C4B5-46C0-9E0D-1C2D4C034B1BQ31011471-7B92C321-8B75-4D20-90EE-E1AF2A6DAB42Q33212981-1FFAE69B-8B46-4E08-830B-BF03D67DD793Q33407866-FC5FBE4B-CF1F-4908-85B9-90F6AD89EB86Q33420255-A3B5ADA6-38C2-4354-88FE-8F7888AB6179Q33518536-41FC4526-8859-4666-A57F-6E8B062C16FEQ33798525-74B8A15E-3AFC-42F3-8AA4-24A35B702484Q33815992-1A0EFC08-D27D-4362-A14F-AE92485891FBQ33822016-F36A8727-5AF7-43D3-BDBE-5FC3617D04E7Q33830733-2E3D77E8-653D-476F-AFC3-FCF9927C4D7FQ33850074-367C0023-F9C4-4518-BBE2-9EEFD83842E7Q33919200-931CA04E-9087-4C7E-A09C-47D8BAA329B1Q33924832-7CB8152D-D36F-4C46-8015-34088E077973Q33982310-AA254490-ECCB-4B74-B577-E7D5A354AA5CQ34122323-89F2A84C-C4F9-4C46-BB90-B15A7527097DQ34135292-D1C80905-9932-4EB5-83F2-2E46201D7CCDQ34326557-89B31000-A26E-4017-AA2E-9B890B51BBBEQ34329516-1E10F9DA-F56D-4FF0-8CA0-85E21CFAAA26Q34382986-31AF6FCC-47EF-4473-9C63-263588F3D5D5Q34449575-6FA65797-FAED-463F-B747-21F220BDC8C8Q34507114-F539DC86-20BD-4875-8EDE-3C302EF1EF8AQ34630756-E49FEE03-7803-4788-A98B-CBCFCB1E5E3CQ34632461-9FF3EC0E-9D87-4DB6-8ACA-0D8390D8F2FCQ34798677-5D6F94B1-13D3-4D35-8A23-3B916626F5A2Q34803868-79187FBC-9117-4B0E-AA93-8727CEAF29ABQ34901206-EDC01318-8516-4597-950E-97BDE4717644Q35210402-D9B9854C-5C77-4FBD-9A50-7CAF296BDD10Q35483640-D1568263-9871-4D49-845C-D9E126145676Q35584788-7A25FD6B-FD54-47F1-B8E1-C8F91CF313A0Q35790006-73C02F7E-6388-4785-8714-C142C471951AQ35819325-72906E7F-7178-4C20-8143-C9F92A208B64Q35941236-C233DCFB-69DA-48F8-8F23-5CD426B22AB3Q35941404-0AE0BFE9-F62B-4553-B39D-7F75ADA9F337Q35994836-2D717198-8A56-41BA-B6CF-6DAF38C2D07DQ36085962-7A639EED-F860-4092-B654-890B518D8E9D
P2860
B-cell chronic lymphocytic leukemia: a bird of a different feather
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
B-cell chronic lymphocytic leukemia: a bird of a different feather
@ast
B-cell chronic lymphocytic leukemia: a bird of a different feather
@en
B-cell chronic lymphocytic leukemia: a bird of a different feather
@nl
type
label
B-cell chronic lymphocytic leukemia: a bird of a different feather
@ast
B-cell chronic lymphocytic leukemia: a bird of a different feather
@en
B-cell chronic lymphocytic leukemia: a bird of a different feather
@nl
prefLabel
B-cell chronic lymphocytic leukemia: a bird of a different feather
@ast
B-cell chronic lymphocytic leukemia: a bird of a different feather
@en
B-cell chronic lymphocytic leukemia: a bird of a different feather
@nl
P3181
P1476
B-cell chronic lymphocytic leukemia: a bird of a different feather
@en
P2093
F Caligaris-Cappio
T J Hamblin
P304
P3181
P356
10.1200/JCO.1999.17.1.399
P407
P577
1999-01-01T00:00:00Z